お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
930640

バーチャル診断の世界市場:診断の種類、エンドユーザー、地域、特許シナリオ、競合環境-分析と予測(2019~2030年)

Global Virtual Diagnostics Market: Focus on Type of Diagnosis, End User, Region, Patent Scenario and Competitive Landscape - Analysis and Forecast, 2019-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 157 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
バーチャル診断の世界市場:診断の種類、エンドユーザー、地域、特許シナリオ、競合環境-分析と予測(2019~2030年)
出版日: 2020年03月18日
発行: BIS Research Inc.
ページ情報: 英文 157 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバーチャル診断市場は、2019~2030年までCAGR15.52%で拡大する見込みです。人工知能の技術的ブレークスルーや世界の様々な地域でのスマートフォンの普及率の高さにより、世界のバーチャル診断市場の成長が期待されています。疾患の早期診断に対する意識向上、診断へのアクセスのしやすさや費用に対する需要の高まりなどが市場成長を牽引する要因となっていますが、一方で、バーチャル診断の精度の低さやプライバシー問題などの課題も残されています。

当レポートでは、世界のバーチャル診断市場について調査し、市場動向、市場シェア予測、競合動向、セグメント別動向、参入企業のプロファイルについてまとめています。

第1章 製品定義

第2章 調査範囲

第3章 調査方法

第4章 業界分析

  • 業界構造
  • 法規制の枠組み
  • 協会、コンソーシアム、規制団体
  • 特許分析

第5章 競合環境

  • 戦略と発展
  • 成長シェア分析
  • 製品マッピング分析

第6章 市場シナリオ

  • 限界と仮定
  • 主な調査結果
  • 市場予測
    • 市場促進因子
    • 市場阻害因子
    • 市場の機会

第7章 診断タイプ別市場

  • 概要
  • 消化器科
  • 眼科
  • 心臓科
  • 病理学
  • その他

第8章 エンドユーザー別市場

  • 概要
  • 病院
  • 専門クリニック、外来外科センター
  • その他

第9章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ、中東・アフリカ

第10章 企業プロファイル

図表

List of Tables

  • Table 4.1: List of Associations/Consortiums/Regulatory Bodies with Year of Establishment and Headquarters
  • Table 5.1: Company Product Mapping Analysis
  • Table 6.1: Impact of Market Drivers, 2019-2030
  • Table 6.2: Impact of Market Restraints, 2019-2030

List of Figures

  • Figure 1: Global Virtual Diagnostics Market Growth, 2018-2030
  • Figure 2: Impact Analysis for Key Market Drivers and Restraints, 2019-2030
  • Figure 3: Share of Key Developments and Strategies, January 2016-January 2020
  • Figure 4: Global Virtual Diagnostics Market (by Region), 2018-2030
  • Figure 5: Global Virtual Diagnostics Market (by Type of Diagnosis and by End User), 2018 and 2030
  • Figure 2.1: Global Virtual Diagnostics Market Segmentation
  • Figure 3.1: Global Virtual Diagnostics Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Shares of Key Companies Profiled
  • Figure 3.5: Assumptions and Limitations
  • Figure 4.1: Number of Patents Filed, January 2015 to December 2019
  • Figure 5.1: Share of Key Developments and Strategies, January 2016 to January 2020
  • Figure 5.2: Analysis of Key Developmental Strategies, by Year, January 2016 to January 2020
  • Figure 5.3: Regulatory and Legal (By Company), January 2016 to January 2020
  • Figure 5.4: Partnerships, Alliances, and Business Expansions (by Company), January 2016 to January 2020
  • Figure 5.5: New Offerings (by Company), January 2016 to January 2020
  • Figure 5.6: Funding Activities (by Company), January 2016 to January 2020
  • Figure 5.7: Growth Share Matrix for Global Virtual Diagnostics Market (by Type of Diagnosis), 2019-2030
  • Figure 5.8: Growth Share Matrix for Global Virtual Diagnostics Market (by End User), 2019-2030
  • Figure 5.9: Growth Share Matrix for Global Virtual Diagnostics Market (by Region), 2019-2030
  • Figure 6.1: Global Virtual Diagnostics Market Incremental Growth Opportunity, 2018-2030
  • Figure 7.1: Global Virtual Diagnostics Market Share (by Type of Diagnosis), 2018 and 2030
  • Figure 7.2: Global Virtual Diagnostics Market (by Type of Diagnosis), 2018-2030
  • Figure 7.3: Global Gastrointestinal Virtual Diagnostics Market, 2018-2030
  • Figure 7.4: Global Ophthalmology Virtual Diagnostics Market, 2018-2030
  • Figure 7.5: Global Cardiology Virtual Diagnostics Market, 2018-2030
  • Figure 7.6: Global Pathology Virtual Diagnostics Market, 2018-2030
  • Figure 7.7: Global Virtual Diagnostics Market for Others Segment, 2018-2030
  • Figure 8.1: Global Virtual Diagnostics Market Share (by End User), 2018 and 2030
  • Figure 8.2: Global Virtual Diagnostics Market (by End User), 2018-2030
  • Figure 8.3: Global Virtual Diagnostics Market for Hospital Segment, 2018-2030
  • Figure 8.4: Global Virtual Diagnostics Market for Speciality Clinics and Ambulatory Surgical Centers, 2018-2030
  • Figure 8.5: Global Virtual Diagnostics Market for Others Segment, 2018-2030
  • Figure 9.1: Global Virtual Diagnostics Market (by Region), 2018-2030
  • Figure 9.2: North America Virtual Diagnostics Market Share (by Country), 2018 and 2030
  • Figure 9.3: North America Virtual Diagnostics Market, 2018-2030
  • Figure 9.4: North America: Market Dynamics
  • Figure 9.5: U.S. Virtual Diagnostics Market, 2018-2030
  • Figure 9.6: Canada Virtual Diagnostics Market, 2018-2030
  • Figure 9.7: Europe Virtual Diagnostics Market Share (by Country), 2018 and 2030
  • Figure 9.8: Europe Virtual Diagnostics Market, 2018-2030
  • Figure 9.9: Europe: Market Dynamics
  • Figure 9.10: Germany Virtual Diagnostics Market, 2018-2030
  • Figure 9.11: France Virtual Diagnostics Market, 2018-2030
  • Figure 9.12: U.K. Virtual Diagnostics Market, 2018-2030
  • Figure 9.13: Italy Virtual Diagnostics Market, 2018-2030
  • Figure 9.14: Spain Virtual Diagnostics Market, 2018-2030
  • Figure 9.15: Rest-of-Europe Virtual Diagnostics Market, 2018-2030
  • Figure 9.16: Asia-Pacific Virtual Diagnostics Market Share (by Country), 2018 and 2030
  • Figure 9.17: Asia-Pacific Virtual Diagnostics Market,2018-2030
  • Figure 9.18: Asia-Pacific: Market Dynamics
  • Figure 9.19: Japan Virtual Diagnostics Market, 2018-2030
  • Figure 9.20: China Virtual Diagnostics Market, 2018-2030
  • Figure 9.21: Australia Virtual Diagnostics Market, 2018-2030
  • Figure 9.22: South Korea Virtual Diagnostics Market, 2018-2030
  • Figure 9.23: India Virtual Diagnostics Market, 2018-2030
  • Figure 9.24: Rest of Asia-Pacific Virtual Diagnostics Market, 2018-2030
  • Figure 9.25: Latin America, Middle East, and Africa Virtual Diagnostics Market, 2018-2030
  • Figure 9.26: Middle East, Latin America, Middle East, and Africa: Market Dynamics
  • Figure 10.1: AliveCor, Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.2: AliveCor, Inc.: SWOT Analysis
  • Figure 10.3: Cardiologs Technologies: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.4: Cardiologs Technologies: SWOT Analysis
  • Figure 10.5: CapsoVision Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.6: CapsoVision, Inc.: SWOT Analysis
  • Figure 10.7: Eyenuk Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.8: Eyenuk Inc.: SWOT Analysis
  • Figure 10.9: Healthy.io Ltd.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.10: Healthy.io. Ltd.: SWOT Analysis
  • Figure 10.11: hearX IP (Pty) Ltd.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.12: hearX IP (Pty) Ltd.: SWOT Analysis
  • Figure 10.13: Hill-Rom Holdings, Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.14: Hill-Rom Holdings, Inc.: Overall Financials, 2017-2019
  • Figure 10.15: Hill-Rom Holdings, Inc.: Revenue (by Segment), 2017-2019
  • Figure 10.16: Hill-Rom Holdings, Inc.: Revenue (by Region), 2017-2019
  • Figure 10.17: Hill-Rom Holdings, Inc.: R&D Expenditure, 2017-2019
  • Figure 10.18: Hill-Rom Holdings, Inc.: SWOT Analysis
  • Figure 10.19: IDx Technologies Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.20: IDx Technologies Inc.: SWOT Analysis
  • Figure 10.21: Medtronic Plc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.22: Medtronic Plc: Overall Financials, 2017-2019
  • Figure 10.23: Medtronic Plc: Revenue (by Segment), 2017-2019
  • Figure 10.24: Medtronic Plc: Revenue (by Region), 2017-2019
  • Figure 10.25: Medtronic Plc: R&D Expenditure, 2017-2019
  • Figure 10.26: Medtronic Plc.: SWOT Analysis
  • Figure 10.27: Monitored Therapeutics Inc.: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.28: Monitored Therapeutics, Inc.: SWOT Analysis
  • Figure 10.29: Olympus Corporation: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.30: Olympus Corporation: Overall Financials, 2016-2018
  • Figure 10.31: Olympus Corporation: Revenue (by Segment), 2016-2018
  • Figure 10.32: Olympus Corporation: Revenue (by Region), 2016-2018
  • Figure 10.33: Olympus Corporation: R&D Expenditure, 2016-2018
  • Figure 10.34: Olympus Corporation: SWOT Analysis
  • Figure 10.35: Phelcom Technologies: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.36: Phelcom Technologies: SWOT Analysis
  • Figure 10.37: ResApp Health Limited: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.38: ResApp Health Limited: SWOT Analysis
  • Figure 10.39: Sight Diagnostics: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.40: Sight Diagnostics: SWOT Analysis
  • Figure 10.41: SkinVision: Product Portfolio for Global Virtual Diagnostics Market
  • Figure 10.42: SkinVision: SWOT Analysis
目次
Product Code: BH195A

Global Virtual Diagnostics Market to Grow at a CAGR of 15.52% from 2019-2030

Key Questions Answered in the Report:

  • What are the key features of virtual diagnostics and what are the different technologies of virtual diagnostics offered in the market?
  • What are the major market drivers, restraints, and opportunities in the global virtual diagnostics market?
  • What are the expected regional and global scenarios of the virtual diagnostics market, and the growth potential of each country in various regions?
  • What are the key development strategies being implemented by the key players in this market?
  • What are the key regulations governing the manufacturing and commercialization of various products in the global virtual diagnostics market?
  • What is the expected growth of the virtual diagnostics market in the forecast period 2019-2030?
  • What are the leading companies dominating the global virtual diagnostics market?
  • How are the key players of the virtual diagnostics market expected to grow in the forecast period?
  • What was the market value of the leading segments of the global virtual diagnostics market in 2018?
  • How is each segment of the global virtual diagnostics market expected to grow during the forecast period, and what is the estimated revenue generation by each of the segments by the end of 2030?
  • Which region is expected to contribute the highest sales in the global virtual diagnostics market during the forecast period?

Global Virtual Diagnostics Market Forecast, 2019-2030

The global virtual diagnostics market industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.52% during the forecast period, 2019-2030. The global virtual diagnostics market generated $425.6 million revenue in 2018, in terms of value.

The market growth in the global virtual diagnostics market can primarily be attributed to the factors such as increasing rising awareness for early disease diagnosis and increasing demand for accessible and affordable diagnostics. However, there are significant challenges which are restraining the market growth. These challenges include low accuracy within virtual diagnosis and increasing privacy concerns among the people worldwide.

Expert Quote

"The technological breakthroughs in artificial intelligence and machine learning technologies along with high adoption rate of smartphones within various regions of the world have paved a way for the growth of global virtual diagnostics market in the forecast period of 2019-2030"

Scope of the Market Intelligence on Global Virtual Diagnostics Market

The research report on global virtual diagnostics market provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the global virtual diagnostics market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying segment, and company, as well as other vital information with respect to global virtual diagnostics market.

Market Segmentation

  • The global virtual diagnostics market is segmented on the basis of type of diagnosis, into Gastrointestinal, Cardiology, Pathology, Ophthalmology, and others.
  • The global virtual diagnostics market is further segmented by end user into hospitals, specialty clinics and ambulatory centers and others.
  • The global virtual diagnostics market on the basis of region is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. The potential of the market with respect to different countries within these regions has also been provided.

Key Companies in the Global Virtual Diagnostics Market

The key manufacturers who have been contributing significantly to the global virtual diagnostics market include Uber Diagnostics, CapsoVision Inc., Cardiologs Technologies, Healthy.io Ltd, IDx Technologies Inc., Monitored Therapeutics, Inc., Olympus Corporation, Phelcom Technologies, Sight Diagnostics, Medtronic Plc, hearX IP (Pty) Ltd, AliveCor, Inc., ResApp Health Limited, and SkinVision among others.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of Work

  • 2.1 Report Coverage
  • 2.2 Exclusions and Inclusion Criteria of the Report
    • 2.2.1 Exclusion Criteria
    • 2.2.2 Inclusion Criteria
  • 2.3 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Overview
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Data Sources Categorization
  • 3.5 Companies Profiled in the Report
  • 3.6 Assumptions and Limitations

4 Industry Analysis

  • 4.1 Industry Structure
    • 4.1.1 Virtual Diagnostics Vendors
    • 4.1.2 Contract Manufacturers
    • 4.1.3 Distributors
  • 4.2 Legal & Regulatory Framework
    • 4.2.1 North America
      • 4.2.1.1 Regulatory Requirements in the U.S.
      • 4.2.1.2 Regulatory Requirements in Canada
    • 4.2.2 Europe
    • 4.2.3 Other Countries
  • 4.3 Associations, Consortiums, and Regulatory Bodies
  • 4.4 Patent Analysis
    • 4.4.1 Patent Filing Trend, January 2015 to December 2019
    • 4.4.2 Awaited Technologies

5 Competitive Landscape

  • 5.1 Overview
  • 5.2 Key Strategies and Developments
    • 5.2.1 Regulatory and Legal Activities
    • 5.2.2 Partnerships, Alliances, Agreements, and Business Expansions
    • 5.2.3 New Offerings
    • 5.2.4 Funding Activities
  • 5.3 Growth Share Analysis
    • 5.3.1 Growth Share Matrix (by Type of Diagnosis)
    • 5.3.2 Growth Share Matrix (by End User)
    • 5.3.3 Growth Share Matrix (by Region)
  • 5.4 Product Mapping Analysis

6 Global Virtual Diagnostics Market Scenario

  • 6.1 Limitations and Assumptions
  • 6.2 Key Findings
  • 6.3 Global Virtual Diagnostics Market and Forecast (2019-2030)
    • 6.3.1 Market Drivers
      • 6.3.1.1 Advancements in Application of Biosensor Technology
      • 6.3.1.2 Rising Gastrointestinal Disorders
      • 6.3.1.3 Technological Breakthroughs in Diagnostic Testing Techniques
      • 6.3.1.4 Increasing Demand for Smartphone-Based Diagnostics
      • 6.3.1.5 High Accessibility to Remote Areas
      • 6.3.1.6 Increasing Awareness in Disease Diagnostics
      • 6.3.1.7 Improved Microscopic Imaging in Smartphones
    • 6.3.2 Market Restraints
      • 6.3.2.1 Hindrance in Privacy through Virtual Diagnostic Methods
      • 6.3.2.2 Risk of Low Accuracy in Diagnosis
    • 6.3.3 Market Opportunities
      • 6.3.3.1 Large Scope of Cross Vertical Collaboration
      • 6.3.3.2 Strong Pipeline of Virtual Diagnostic Products and Platforms

7 Global Virtual Diagnostics Market (by Type of Diagnosis)

  • 7.1 Overview
  • 7.2 Gastrointestinal Virtual Diagnostics Market
  • 7.3 Ophthalmology Virtual Diagnostics Market
  • 7.4 Cardiology Virtual Diagnostics Market
  • 7.5 Pathology Virtual Diagnostics Market
  • 7.6 Others Virtual Diagnostics Market

8 Global Virtual Diagnostics Market (by End User)

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Specialty Clinics and Ambulatory Surgical Centers
  • 8.4 Others (Homecare and Research Institutes)

9 Global Virtual Diagnostics Market (by Region)

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K.
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 Australia
    • 9.4.4 South Korea
    • 9.4.5 India
    • 9.4.6 Rest-of-Asia-Pacific
  • 9.5 Latin America, Middle East, and Africa

10 Company Profiles

  • 10.1 AliveCor Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Role of Alivecor, Inc. in the Global Virtual Diagnostics Market
    • 10.1.3 SWOT Analysis
  • 10.2 Cardiologs Technologies
    • 10.2.1 Company Overview
    • 10.2.2 Role of Cardiologs Technologies in the Global Virtual Diagnostics Market
    • 10.2.3 SWOT Analysis
  • 10.3 CapsoVision, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of CapsoVision, Inc. in the Global Virtual Diagnostics Market
    • 10.3.3 SWOT Analysis
  • 10.4 Eyenuk, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Role of Eyenuk Inc. in the Global Virtual Diagnostics Market
    • 10.4.3 SWOT Analysis
  • 10.5 Healthy.io Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Role of Healthy.io Ltd. in the Global Virtual Diagnostics Market
    • 10.5.3 SWOT Analysis
  • 10.6 hearX IP (Pty) Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Role of hearX IP (Pty) Ltd. in the Global Virtual Diagnostics Market
    • 10.6.3 SWOT Analysis
  • 10.7 Hill-Rom Holdings, Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Role of Hill-Rom Holdings, Inc in the Global Virtual Diagnostics Market
    • 10.7.3 Financials
    • 10.7.4 SWOT Analysis
  • 10.8 IDx Technologies Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Role of IDx Technologies Inc. in the Global Virtual Diagnostics Market
    • 10.8.3 SWOT Analysis
  • 10.9 Medtronic Plc.
    • 10.9.1 Company Overview
    • 10.9.2 Role of Medtronic Plc. in the Global Virtual Diagnostics Market
    • 10.9.3 Financials
    • 10.9.4 SWOT Analysis
  • 10.10 Monitored Therapeutics Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Role of Monitored Therapeutics Inc. in the Global Virtual Diagnostics Market
    • 10.10.3 SWOT Analysis
  • 10.11 Olympus Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Role of Olympus Corporation in the Global Virtual Diagnostics Market
    • 10.11.3 Financials
    • 10.11.4 SWOT Analysis
  • 10.12 Phelcom Technologies
    • 10.12.1 Company Overview
    • 10.12.2 Role of Phelcom Technologies in the Global Virtual Diagnostics Market
    • 10.12.3 SWOT Analysis
  • 10.13 ResApp Health Limited
    • 10.13.1 Company Overview
    • 10.13.2 Role of ResApp Health Limited in the Global Virtual Diagnostics Market
    • 10.13.3 SWOT Analysis
  • 10.14 Sight Diagnostics
    • 10.14.1 Company Overview
    • 10.14.2 Role of Sight Diagnostics in the Global Virtual Diagnostics Market
    • 10.14.3 SWOT Analysis
  • 10.15 SkinVision
    • 10.15.1 Company Overview
    • 10.15.2 Role of SkinVision in the Global Virtual Diagnostics Market
    • 10.15.3 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.